How Becker was paid
$2.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Joel BeckerPresident and Chief Executive Officer | $567,567 | $587,340 | $701,850 | $551,810 | — | $2,408,566 |
| Patrick WilliamsChief Financial Officer | $263,461 | $539,759 | $650,452 | $192,263 | — | $1,645,935 |
| Martha Morrell, M.D.Chief Medical Officer | $489,842 | $140,634 | $168,183 | $235,473 | — | $1,034,132 |
| Rebecca KuhnFormer Chief Financial Officer, Vice President, Finance and Administration | $268,166 | $117,468 | $140,441 | — | $320,233 | $846,308 |
What changed and why
- $3MCEO total compensation decreased from $3,024,894 in 2024 to $2,408,566 in 2025 due to lower equity award values.
- $568KMr. Becker received a base salary of $567,567 along with $587,340 in stock awards and $701,850 in option awards.
- 120%Corporate bonus attainment was determined to be 120% for Mr. Becker and Mr. Williams, and 109.1% for Dr. Morrell.
- Patrick Williams was appointed as Chief Financial Officer in June 2025, receiving sign-on equity and new hire equity awards.
- Rebecca Kuhn ceased employment as Chief Financial Officer in June 2025, receiving severance and pro-rated incentive compensation.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.